In one study, CLDN6 was expressed at low levels in a CRC cell line (SW1116); when CLDN6 was experimentally overexpressed, it suppressed the cells’ migratory and invasive abilities, apparently by activating the tumor-suppressive TYK2/STAT3 pathway (60). This evidence concerns the gene TYK2 and neoplasm.